{"database": "press", "table": "releases", "rows": [["https://www.moran.senate.gov/public/index.cfm/news-releases?ID=BFDDC31B-2469-4F0E-AB00-14261CE08666", "Sen. Moran Applauds Department of Commerce\u2019s Designation of KC Metro as a Tech Hub", "2023-10-23", "2023", "2023-10", "Republican", "Senate", "KS", "Jerry Moran", "M000934", "www.moran.senate.gov", "moran", "https://www.moran.senate.gov/public/index.cfm/news-releases", "scraper", "WASHINGTON \u2013 U.S. Senator Jerry Moran (R-Kan.) today applauded the U.S. Department of Commerce\u2019s Economic Development Administration (EDA) decision to designate Kansas City Inclusive Biologics and Biomanufacturing Tech Hub (KC BioHub) as one of the 31 inaugural Tech Hubs in regions across the country that show potential for rapid growth in key technology sectors.\n\nKC BioHub, a consortium led by BioNexus KC, will increase domestic production of vaccines and other preventative technologies by strengthening innovation in animal and human vaccine development. With the largest concentration of animal health and nutrition companies in the world, this Tech Hub will leverage the region\u2019s biotechnology assets and existing vaccine manufacturing facilities, research institutions, and startup ecosystem to enable the U.S. to capture a greater market share of human vaccine development.\n\n\u201cThis announcement represents official recognition of something we have known in Kansas and Missouri for awhile: the Kansas City region and the Animal Health Corridor have the concentration of expertise and research and development resources necessary to be a global bio and medical technology hub,\u201d said Sen. Moran. \u201cThis designation will attract public and private resources to grow this key technology area in Kansas and Missouri, further expanding the region\u2019s capacity for innovation in the biotech sector. I supported the CHIPS and Science Act to give organizations in Kansas the opportunity to help strengthen our national and economic security, particularly by increasing research in key technology areas, like biotechnology. I applaud the efforts of BioNexus and the other consortium of members in Kansas and Missouri on a successful Tech Hubs application.\u201d\n\nThis designation is part of the first phase of the novel Tech Hubs program, authorized by the CHIPS and Science Act, that will invest directly in high-potential U.S. regions and aim to transform them into globally competitive innovation centers. Designation is an endorsement of the region\u2019s strategy to supercharge their respective technological industry to create jobs and strengthen U.S. economic and national security. Designated Tech Hubs are now eligible to apply for the next phase of the Tech Hubs Program that will invest between $50-$75 million in each of 5-10 Designated Hubs.\n\n# # #", 1, "2026-03-30T01:40:41Z", "2026-04-06T18:43:12Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://www.moran.senate.gov/public/index.cfm/news-releases?ID=BFDDC31B-2469-4F0E-AB00-14261CE08666"], "units": {}, "query_ms": 2.0982488058507442, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}